Best GLP-1 Providers in Georgia (2026)

See by medication

Looking for a specific GLP-1? Browse Georgia providers by drug.

About GLP-1s in Georgia

Georgia allows telehealth GLP-1 prescribing. Georgia Medicaid covers GLP-1s only for type 2 diabetes with prior authorization.

• •Georgia's adult obesity rate is 34.1%
• •Georgia Medicaid restricts GLP-1 coverage to diabetes
• •Atlanta is a major hub for telehealth weight loss providers

Top Cities for GLP-1 Treatment in Georgia

Telehealth providers ship to all Georgia addresses, but demand is highest in these metro areas:

Prefer an in-person clinic? Browse the Georgia GLP-1 clinic directory →

GLP-1 Care Access in Georgia: The Numbers

Georgia has 976 NPI-registered in-person weight-management clinics across 140 cities — 23 with an obesity-medicine taxonomy, 340 endocrinology, and 617 bariatric — alongside 98 telehealth programs that ship to Georgia addresses. The cheapest verified ongoing compounded semaglutide price available to Georgia residents is $65/mo (tirzepatide: $97/mo). Full methodology and the 50-state table: GLP-1 care access by state.

Insurance & Medicaid in Georgia

In Q1 2026, Georgia Medicaid reimbursed approximately $14,717,692 across 16,197 GLP-1 prescriptions (all covered indications, gross before rebates — federal SDUD data; full state series here).

Most insurance plans in Georgia cover GLP-1s for type 2 diabetes (Ozempic, Mounjaro), but coverage for obesity-only indications (Wegovy, Zepbound) is much more limited and often requires prior authorization. If your insurance won't cover brand-name GLP-1s, compounded semaglutide through telehealth is typically the most affordable option at around $195/mo.

For the exact criteria, drug list, and appeal process, read our Georgia Medicaid GLP-1 coverage & prior-authorization guide. For coverage backdoors, Zepbound is FDA-approved for obstructive sleep apnea, and Wegovy for kidney and cardiovascular indications, which some plans cover even when they exclude weight-loss-only use.

Obesity in Georgia

According to CDC data, 34.1% of Georgia adults have obesity (BMI of 30 or higher). This places Georgia at #15 out of 50 states. Access to GLP-1 medications like semaglutide and tirzepatide has expanded significantly through telehealth, helping Georgia residents get clinically supervised weight loss treatment from home.

To choose a medication, compare the clinical-trial results behind each drug, see our best semaglutide and tirzepatide provider rankings, or track the next-generation GLP-1 pipeline.

Frequently Asked Questions